Women's Health

Light Search completed

Invite

Radar Tracking

Subspaces (5)

Wearable Health Devices

Mobile Health Applications

Artificial Intelligence in Women's Health Care

Genomic and Genetic Testing

Health Information Systems

Pending to review

Not sure yet

Interested

Not interested

Download list

Showing 60 results

Company	Fit assessment	Description	Subspaces	Tags	HQ Location	Founding Date	Employees	Total Funding Raised	Last Funding Event	Received on
Kiira	Kiira Health enhances women's healthcare by connecting them with trusted providers and utilizing advanced AI for care coordination.	Operator of an artificial intelligence (AI) based telehealth platform designed to meet women's healthcare needs. The company's platform connects users with trusted primary care physicians, obstetrics, gynecologists, nurses, and therapists, enabling women to get expert advice about personal health problems.	Artificial Intelligence in Women's Health Care	New Light Search	United States	2018	50	$4.00M	Venture - Series Unknown, October 6, 2022	Oct 15, 2024
RGCS	RGCS develops technologies focused on women's health through reproductive genetics and provides advanced genetic testing solutions.	RGCS is one of the premium Next Generation Sequencing (NGS)-based genomics company in India. It is dedicated in providing molecular diagnostic solutions in the domains of Reproductive Genetics, Cancer Genetics, and Pharmacgenomics for personalised medicine to drive the next generation precision medicine.	Genomic and Genetic Testing	New Light Search	India	2018	51 - 200		NA	Oct 15, 2024
Genetic Technologies	Genetic Technologies focuses on women's health through predictive testing and provides diagnostic tools that enhance women's health outcomes.	Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.	Genomic and Genetic Testing	New Light Search	Australia	1989	51 - 200	$2.00M	Post-IPO Equity, $2.00M, April 19, 2024	Oct 15, 2024
Ava (Monitoring Equipment)	Ava offers a patented multi-sensor bracelet that helps women track their menstrual cycle and fertility, providing real-time data on their reproductive health. The technology is clinically validated and aims to empower women in managing their fertility and overall health.	Manufacturer and designer of a wearable medical device designed to be used for monitoring a woman's fertility and menstrual cycle. The company's initial product consists of a sophisticated sensor bracelet, an app, and a powerful backend with self-learning algorithms for interpretation of hormonal changes, accurate ovulation tracking, and screening of women's health issues, enabling women to get reliable data about their fertility, pregnancy and menopause.	Artificial Intelligence in Women's Health Care	New Light Search	Switzerland	2014	51 - 200	$42.44M	Acquired by FemTec Health, July 2022	Oct 15, 2024
Life in Genomics	Life in Genomics focuses on women's health through prenatal and genomic testing, enhancing diagnosis and providing personalized healthcare strategies.	The company primarily operates in the Biotechnology industry. Life in Genomics was founded in 2014 and is headquartered in México, Mexico.	Genomic and Genetic Testing	New Light Search	Mexico	2014	11 - 50		NA	Oct 15, 2024
Reveal Genomics	REVEAL GENOMICS develops innovative genomic tools that enhance diagnosis, treatment, and care for women's health, particularly in oncology.	Developer of oncology tests designed to make use of the complete genetic and clinical information of each patient. The company analyzes complex genomic and clinical data and decodes biomarkers before, during, or after therapies using different biopsy-based approaches and revealing innovative tests of high analytical complexity, improving the health and well-being of patients with breast and other types of cancer.	Genomic and Genetic Testing	New Light Search	Spain	2020	1 - 10		NA	Oct 15, 2024
GenepoweRx	GenepoweRx focuses on women's health through genetic testing and personalized care, enhancing diagnosis, treatment, and overall care for women.	Operator of a biotechnology company intended to Improve the individual quality of life derived from advanced genomics and overall health profile by bringing genomic solutions to mainstream clinical practices. The company offers a wide range of products and services such as blood sample collection, clinically actionable reports and recommendations, and more, while combining genomics with medical data and lifestyle factors to provide comprehensive and personalized care to patients by utilizing next-generation sequencing.	Genomic and Genetic Testing	New Light Search	India	2019	11 - 50		NA	Oct 15, 2024
GynTools	Gyntools develops innovative diagnostic solutions for women's health, significantly improving diagnosis, treatment, and care through AI technology.	Developer of a AI-based diagnostic tool designed to improve women's health. The company's tool is designed to diagnose various causes of vaginal inflammation presenting with discharge, itch, or pain, enabling gynecologists to understand their patient's conditions and make personalized and effective treatment decisions.	Artificial Intelligence in Women's Health Care	New Light Search	Israel	2016	3	$2.06M	Grant, $26.80K, June 6, 2024	Oct 15, 2024
Invitae	Invitae is a genetic information company focused on integrating genetic diagnostics into healthcare, offering a wide range of tests for hereditary conditions, including those related to reproductive health. They aim to make genetic testing more accessible and affordable while providing actionable insights for patients and clinicians.	Invitae Corp operates as a genetic information company in diagnostic and research industry. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions.	Genomic and Genetic Testing	New Light Search	United States	2010	1001 - 5000	$3.43B	Acquired by LabCorp, April 2024	Oct 15, 2024
Gene Solutions	Gene Solutions focuses on women's health through genetic testing solutions, enhancing personalized healthcare strategies for reproductive health.	Developer of genetic research and diagnostic technology intended to improve public health. The company offers care products for pregnancy, prenatal diagnosis, control of general diseases, cancer biology and diagnosis of diseases, thereby providing patients with genetic tests that improve screening, diagnosis and treatment at affordable costs.	Genomic and Genetic Testing	New Light Search	Vietnam	2018	501 - 1000	$36.00M	Debt Financing, June 19, 2024	Oct 15, 2024